About Prostate Cancer Screening
Merita Health offers comprehensive prostate cancer screening using PSA testing and digital rectal examination (DRE) to detect prostate abnormalities early when treatment is most effective. Early detection saves lives, and our screening program provides reliable testing for men, particularly those over 40.
Our Screening Methods
- PSA Blood Test: Measures Prostate-Specific Antigen levels in the blood
- Digital Rectal Examination (DRE): Physical examination of the prostate
- Free PSA Ratio: Differentiates between benign and cancerous conditions
- PSA Velocity: Monitors changes in PSA levels over time
Who Should Get Screened?
We recommend prostate cancer screening for:
- Men aged 50+ (average risk)
- Men aged 45+ (high risk - African descent or family history)
- Men aged 40+ (very high risk - multiple family members affected)
- Men with urinary symptoms
- Men with family history of prostate cancer
Screening Recommendations
| Risk Category |
Starting Age |
Frequency |
| Average Risk |
50 years |
Every 2 years |
| High Risk |
45 years |
Every 1-2 years |
| Very High Risk |
40 years |
Yearly |
The Screening Process
- Initial consultation and risk assessment
- PSA blood test (fasting not required)
- Digital rectal examination (DRE)
- Results discussion within 1 week
- Follow-up plan based on results
Benefits of Regular Screening
- Early detection of prostate cancer
- Increased treatment success rates
- Peace of mind and health monitoring
- Better management of prostate health
- Reduced mortality from prostate cancer
